jRCT2080221472未知3 期
Open-label study to assess efficacy and safety of a single dose (i.v.) of NMA78 in patients with Parkinson's Syndrome (PS) or Essential Tremor (ET) and healthy volunteers (HV)
试验速览
- 阶段
- 3 期
- 入组人数
- 24
- 主要终点
- diagnostic accuracy by reading committee
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Non-randomized, open-label
入排标准
- 年龄范围
- 35age old over 至 No limit（—）
- 性别
- All
入选标准
- •Healthy Japanese people.
- •Japanese patients clinically- diagnosed with PD.
- •Japanese patients clinically- diagnosed with MSA.
- •Japanese patients clinically- diagnosed with PSP.
- •Japanese patients clinically- diagnosed with ET.
排除标准
- •Patients clinically-diagnosed with dementia.
- •Patients using following drugs: cocaine hydrochloride, mazindol, methylphenidate hydrochloride, sertraline hydrochloride.
- •Patients with hepatic, renal or hematopoietic dysfunction.
- •People with allergic reaction to alcohol or iodine.
- •Women who are pregnant, lactating or possibly pregnant.
结局指标
主要结局
diagnostic accuracy by reading committee
Efficacy
subjective/objective symptoms, vital signs, electrocardiogram, clinical tests
Safety
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
Open-label study to assess efficacy and safety of a single dose (i.v.) of NMA78 in PS or ET patients and HVPS:Parkinson's Disease (PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy(PSP), ETJPRN-jRCT2080221472ihon Medi-Physics Co., Ltd.24
未知
3 期
Open-label study to assess efficacy and safety of a single dose (i.v.) of NMA78 in DLB or AD patients and HVDLB, ADJPRN-jRCT2080221473ihon Medi-Physics Co., Ltd.18
已完成
2 期
Open-label study to assess efficacy and safety of a single dose (i.v.) of NMK36 in subjects with high / low- grade glioma.jRCT2080222240Nihon Medi-Physics Co., Ltd.35
未知
3 期
Open-label study to assess efficacy and safety of a single dose (i.v.) of NMA78 in DLB or AD patients and HVjRCT2080221473Nihon Medi-Physics Co., Ltd.18
已完成
不适用
Treatment of severe chronic migraines with injections of stem cells obtained from patients' own fat tissueChronic migraine, refractory to treatmentNervous System DiseasesISRCTN72512465ew York Headache Center10